Fig. 6From: Enhancement of Cetuximab-Induced Radiosensitization by JAK-1 InhibitionThe use of JAK1i (1 μM) combined with cetuximab (0.5 μg/ml) prior to radiation resulted in marked radiosensitization in UM-SCC-1 cells. JAK1i alone or cetuximab alone did not result in radiosensitization. The data represent the mean and standard error of three assessmentsBack to article page